Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes
Clinical trial NCT02868177 · COMPLETED
Trial details
- NCT number
- NCT02868177
- Sponsor
- Valbiotis
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2019-04-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.